BC ORIGINAL FORMULA

Compare BC ORIGINAL FORMULA  to:
Compare
Compare

Generic Name for BC ORIGINAL FORMULA

Aspirin 650mg, caffeine 33.3mg, salicylamide 195mg; per powder; contains potassium 55mg/powder.

Legal Classification:

OTC

Pharmacological Class for BC ORIGINAL FORMULA

Salicylate.

Manufacturer of BC ORIGINAL FORMULA

GlaxoSmithKline Pharmaceuticals

Indications for BC ORIGINAL FORMULA

Pain. Fever.

Adult dose for BC ORIGINAL FORMULA

Place powder on tongue and follow with liquid; or may stir into glass of water or other liquids. 1 powder every 3–4 hours; max: 4 powders/24 hours.

Children's dosing for BC ORIGINAL FORMULA

Not recommended.

Contraindications for BC ORIGINAL FORMULA

NSAID allergy. Viral infection in children and teenagers. 3rd trimester pregnancy.

Precautions for BC ORIGINAL FORMULA

History of asthma or peptic ulcer. Severe hepatic or renal dysfunction. Bleeding disorders. Diabetes. Gout. Pregnancy. Nursing mothers: not recommended.

Interactions for BC ORIGINAL FORMULA

Potentiates anticoagulants, hypoglycemics, methotrexate, acetazolamide, valproic acid, highly protein-bound drugs. Urinary alkalinizers, antacids, corticosteroids may increase excretion. May antagonize ACE inhibitors, β-blockers, diuretics, uricosurics. Increased bleeding risk with NSAIDs or chronic, heavy alcohol use. NSAIDs increase risk of renal dysfunction. Additive effects with other caffeine-containing products.

Adverse Reactions for BC ORIGINAL FORMULA

GI upset/bleed, prolonged bleeding time, anaphylaxis, salicylism.

How is BC ORIGINAL FORMULA supplied?

Powder—2, 6, 18, 24, 50

Related Disease:

Pain, general~nonnarcotics

Related Resources

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

McNeil Consumer Healthcare recalls certain over-the-counter (OTC) products

January 15, 2010

McNeil Consumer Healthcare and the FDA have announced a voluntary recall of certain lots of over-the-counter products, including Tylenol (acetaminophen), Motrin IB (ibuprofen), St. Joseph Aspirin (aspirin), Simply Sleep (diphenhydramine), and Rolaids (calcium carbonate and magnesium hydroxide).

Naprelan Dose Card blister packs launched

November 23, 2009

Victory Pharma announces the availability of Naprelan (naproxen) Dose Card, a single blister pack which provides a ten day, tapered dose regimen of naproxen.

Phase 2 study of Civamide Patch for post-herpetic neuralgia (PHN)

November 16, 2009

Winston Laboratories announced positive top-line results from Study WL1001-04-03, a Phase 2 clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide in the treatment of post-herpetic neuralgia (PHN).

Lusedra available for monitored anesthesia care sedation

November 16, 2009

Eisai has made available Lusedra (fospropofol disodium injection), an intravenous water-soluble prodrug of the sedative-hypnotic agent propofol, for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.